Helicobacter pylorieradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial

التفاصيل البيبلوغرافية
العنوان:	Helicobacter pylorieradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial
المؤلفون:	Hawkey, Chris, Avery, Anthony, Coupland, Carol A C, Crooks, Colin, Dumbleton, Jennifer, Hobbs, F D Richard, Kendrick, Denise, Moore, Michael, Morris, Clive, Rubin, Gregory, Smith, Murray, Stevenson, Diane, Mant, David CA, Ford, Alexander C, Macdonald, Thomas M, Bradburn, Mike, Klauza, Claire A, Shone, Angela, Logan, Richard FA, Deeks, Jonathan J, McColl, Kenneth E.L., Goddard, Andrew F, Stevens, Richard, Sami, Sarned, Haughney, John, Cupples, Margaret E, Morar, Monique, O'Brien, Wendy
المصدر:	The Lancet; November 2022, Vol. 400 Issue: 10363 p1597-1606, 10p
مستخلص:	Peptic ulcers in patients receiving aspirin are associated with Helicobacter pyloriinfection. We aimed to investigate whether H pylorieradication would protect against aspirin-associated ulcer bleeding.
قاعدة البيانات:	Supplemental Index

الوصف
تدمد:	01406736 1474547X
DOI:	10.1016/S0140-6736(22)01843-8